In March 2013, the Food and Drug Administration (FDA) approved the sale and marketing of Invokana (canaglifozin). Invokana is in a class of drugs know...
Before the FDA approved Invokana in 2013, concerns were raised about the diabetes drug’s potential to cause heart problems. In January 2013, a review ...